[(1S,2S,4R,8R,9S,10Z,12R)-11-[[(2R,3S,4R,5R)-3-acetyloxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-12-methoxy-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (Z)-3-(3-methyl-1,2-dihydroimidazol-5-yl)prop-2-enoate

C35H50N2O10 — CID 11802469

About [(1S,2S,4R,8R,9S,10Z,12R)-11-[[(2R,3S,4R,5R)-3-acetyloxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-12-methoxy-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (Z)-3-(3-methyl-1,2-dihydroimidazol-5-yl)prop-2-enoate

[(1S,2S,4R,8R,9S,10Z,12R)-11-[[(2R,3S,4R,5R)-3-acetyloxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-12-methoxy-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (Z)-3-(3-methyl-1,2-dihydroimidazol-5-yl)prop-2-enoate (PubChem CID 11802469) has the molecular formula C35H50N2O10 and a molecular weight of 658.79 g/mol. Its IUPAC name is [(1S,2S,4R,8R,9S,10Z,12R)-11-[[(2R,3S,4R,5R)-3-acetyloxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-12-methoxy-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (Z)-3-(3-methyl-1,2-dihydroimidazol-5-yl)prop-2-enoate.

Molecular Properties

• Compound Name: [(1S,2S,4R,8R,9S,10Z,12R)-11-[[(2R,3S,4R,5R)-3-acetyloxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-12-methoxy-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (Z)-3-(3-methyl-1,2-dihydroimidazol-5-yl)prop-2-enoate
• PubChem CID: 11802469
• Molecular Formula: C35H50N2O10
• Molecular Weight: 658.79 g/mol
• Exact Mass: 658.35
• IUPAC Name: [(1S,2S,4R,8R,9S,10Z,12R)-11-[[(2R,3S,4R,5R)-3-acetyloxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-12-methoxy-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (Z)-3-(3-methyl-1,2-dihydroimidazol-5-yl)prop-2-enoate
• SMILES: CO[C@]12C=C[C@](C)(O1)[C@@H](OC(=O)/C=C\C1=CN(C)CN1)C[C@H]1C(C)=CC[C@H](C(C)C)[C@H]1/C=C\2CO[C@@H]1OC[C@@H](O)[C@@H](O)[C@@H]1OC(C)=O
• InChI: InChI=1S/C35H50N2O10/c1-20(2)25-10-8-21(3)26-15-29(46-30(40)11-9-24-16-37(6)19-36-24)34(5)12-13-35(42-7,47-34)23(14-27(25)26)17-43-33-32(45-22(4)38)31(41)28(39)18-44-33/h8-9,11-14,16,20,25-29,31-33,36,39,41H,10,15,17-19H2,1-7H3/b11-9-,23-14-/t25-,26+,27-,28-,29+,31-,32+,33-,34+,35-/m1/s1
• InChIKey: VOCRFMYDZFOMQR-PSVBKHGWSA-N
• XLogP: 2.69
• TPSA: 145.25 Ų
• H-Bond Donors: 3
• H-Bond Acceptors: 12
• Rotatable Bonds: 9
• Heavy Atoms: 47
• Complexity: —

Lipinski Rule of Five

2 violations

Rule	Value
MW ≤ 500	658.79
LogP ≤ 5	2.69
H-Bond Donors ≤ 5	3
H-Bond Acceptors ≤ 10	12

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of [(1S,2S,4R,8R,9S,10Z,12R)-11-[[(2R,3S,4R,5R)-3-acetyloxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-12-methoxy-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (Z)-3-(3-methyl-1,2-dihydroimidazol-5-yl)prop-2-enoate?

The IUPAC name of [(1S,2S,4R,8R,9S,10Z,12R)-11-[[(2R,3S,4R,5R)-3-acetyloxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-12-methoxy-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (Z)-3-(3-methyl-1,2-dihydroimidazol-5-yl)prop-2-enoate (CID 11802469) is [(1S,2S,4R,8R,9S,10Z,12R)-11-[[(2R,3S,4R,5R)-3-acetyloxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-12-methoxy-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (Z)-3-(3-methyl-1,2-dihydroimidazol-5-yl)prop-2-enoate.

What is the SMILES notation for [(1S,2S,4R,8R,9S,10Z,12R)-11-[[(2R,3S,4R,5R)-3-acetyloxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-12-methoxy-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (Z)-3-(3-methyl-1,2-dihydroimidazol-5-yl)prop-2-enoate?

The canonical SMILES for [(1S,2S,4R,8R,9S,10Z,12R)-11-[[(2R,3S,4R,5R)-3-acetyloxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-12-methoxy-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (Z)-3-(3-methyl-1,2-dihydroimidazol-5-yl)prop-2-enoate is CO[C@]12C=C[C@](C)(O1)[C@@H](OC(=O)/C=C\C1=CN(C)CN1)C[C@H]1C(C)=CC[C@H](C(C)C)[C@H]1/C=C\2CO[C@@H]1OC[C@@H](O)[C@@H](O)[C@@H]1OC(C)=O.

What is the InChIKey of [(1S,2S,4R,8R,9S,10Z,12R)-11-[[(2R,3S,4R,5R)-3-acetyloxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-12-methoxy-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (Z)-3-(3-methyl-1,2-dihydroimidazol-5-yl)prop-2-enoate?

The InChIKey is VOCRFMYDZFOMQR-PSVBKHGWSA-N. The full InChI is InChI=1S/C35H50N2O10/c1-20(2)25-10-8-21(3)26-15-29(46-30(40)11-9-24-16-37(6)19-36-24)34(5)12-13-35(42-7,47-34)23(14-27(25)26)17-43-33-32(45-22(4)38)31(41)28(39)18-44-33/h8-9,11-14,16,20,25-29,31-33,36,39,41H,10,15,17-19H2,1-7H3/b11-9-,23-14-/t25-,26+,27-,28-,29+,31-,32+,33-,34+,35-/m1/s1.

What are the key properties of [(1S,2S,4R,8R,9S,10Z,12R)-11-[[(2R,3S,4R,5R)-3-acetyloxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-12-methoxy-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (Z)-3-(3-methyl-1,2-dihydroimidazol-5-yl)prop-2-enoate?

[(1S,2S,4R,8R,9S,10Z,12R)-11-[[(2R,3S,4R,5R)-3-acetyloxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-12-methoxy-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (Z)-3-(3-methyl-1,2-dihydroimidazol-5-yl)prop-2-enoate has a molecular weight of 658.79 g/mol, XLogP of 2.69, 9 rotatable bonds, 3 hydrogen bond donors, and 12 hydrogen bond acceptors.

Where does this data come from?

All data for [(1S,2S,4R,8R,9S,10Z,12R)-11-[[(2R,3S,4R,5R)-3-acetyloxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-12-methoxy-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (Z)-3-(3-methyl-1,2-dihydroimidazol-5-yl)prop-2-enoate is sourced from PubChem (CID 11802469), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).